Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Dent disease 2 is an X-linked recessive renal tubulopathy characterized by low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, and progressive renal failure. It arises from loss-of-function mutations in OCRL, encoding a phosphatidylinositol 4,5-bisphosphate 5-phosphatase, and represents a milder allelic variant of Lowe syndrome without congenital cataracts or metabolic acidosis.
Genetic studies in CLCN5-negative families identified pathogenic OCRL variants in 5 of 13 pedigrees with a Dent phenotype, confirming OCRL as a second Dent disease gene and establishing genetic heterogeneity (5 families) (PMID:15627218). Variant classes include truncating, splice-site, and missense changes, such as c.952C>T (p.Arg318Cys), segregating in affected males.
Supplementary case reports expand the spectrum with splice-site alterations (e.g., c.388+3A>G) presenting with atypical Dent-2 phenotypes and mild extrarenal features (PMID:23047739).
Functional assays in patient fibroblasts demonstrate markedly reduced PIP2 5-phosphatase activity and absence of OCRL protein on western blot, accompanied by impaired endosomal trafficking, supporting a loss-of-function mechanism (PMID:15627218).
OCRL mutations also underlie Lowe syndrome; however, Dent-2 variants typically cluster outside critical catalytic residues and preserve residual enzyme activity, correlating mutation location with phenotype distinction (PMID:19390221).
Integrating genetic and experimental data yields a Strong gene-disease association. OCRL testing is recommended in CLCN5-negative patients with a Dent phenotype to enable accurate diagnosis, prognosis, and familial counseling.
Key Take-home: Genetic screening of OCRL guides the diagnosis of Dent disease 2 and informs clinical management.
Gene–Disease AssociationStrong5 families with OCRL mutations in Dent disease phenotype (PMID:15627218), consistent clinical segregation Genetic EvidenceStrongAt least 5 distinct OCRL variants in 5 families (PMID:15627218) with X-linked segregation Functional EvidenceModerateMarked reduction of PIP2 5-phosphatase activity and endosomal trafficking defects in patient fibroblasts (PMID:15627218) |